Aspen Lowers Offer For Sigma To $552M
South African drugmaker Aspen Pharmacare Holdings Ltd. has slashed its bid to acquire Sigma Pharmaceuticals Ltd. by 8 percent to AU$648 million ($552 million) and placed restrictions on the proposed deal...To view the full article, register now.
Already a subscriber? Click here to view full article